Why Is the Medical Imaging Market Reaching US$59.3 Billion by 2031? U.S. Buyers Tackle Quality Control, Product Recalls and Throughput Challenges

The Global Medical Imaging Market reached US$46.67 billion in 2025 and is projected to reach US$76.75 billion by 2035, growing at a 5.1% CAGR. The market is driven by rising demand for advanced diagnostic imaging, increasing healthcare investment, and continued technological advancements in medical imaging systems.
For U.S. buyers, however, the immediate commercial question is increasingly operational: how can manufacturers, hospitals and diagnostic providers improve quality, throughput and equipment readiness while managing product-recall exposure?
This creates a stronger purchasing case for quality-control automation, software upgrades, service contracts and specialized clinical applications, particularly in Cardiology and Diagnostic Centers.

Request Exclusive Sample (Top Performing Strategies (Next 5 years):
https://www.datamintelligence.com/download-sample/medical-imaging-market?mg

Recent Official Developments

✅ February 2026: The FDA's updated Quality Management System Regulation (QMSR) became effective, incorporating ISO 13485:2016 into the U.S. medical-device quality framework. The FDA also moved to a revised inspection process for medical-device manufacturers.

✅ February 2026: The FDA issued final guidance on Computer Software Assurance for Production and Quality Management System Software. The guidance recommends a risk-based approach for establishing confidence in automated systems used in medical-device production and quality management.

✅ June 2026: The FDA classified recalls involving Siemens ARTIS icono and ARTIS pheno interventional fluoroscopic X-ray systems as Class II recalls. The products are relevant to image-guided and interventional procedures, making post-market quality controls and supplier qualification important considerations for healthcare providers.

✅ June 2026: The FDA reported a recall involving GE HealthCare's Optima XR240amx mobile digital radiographic system after the manufacturer identified a safety-testing issue following column replacement. The case demonstrates why service procedures, functional testing and maintenance controls can affect imaging-equipment readiness.

Purchase This Exclusive Report: https://www.datamintelligence.com/buy-now-page?report=medical-imaging-market?mg
Additional Benifits:
✅ Get Interactive Dashboard Access (With No Additional Coast)
✅ Three months of analyst support to answer queries related to the report.

Buying Trigger: Product Recalls and Quality-Control Exposure

Medical imaging equipment combines complex hardware, software, electronics and clinical workflows. A failure in any one of these areas can create consequences beyond equipment downtime.

The FDA recall database includes recent actions involving imaging systems and software. For example, a 2026 recall involving GE HealthCare's AW Server identified a context-synchronization issue that could cause the system to open the previous patient's examination, potentially leading to incorrect interpretation or clinical decisions.

For U.S. buyers, this changes the supplier-qualification discussion.
Procurement teams increasingly need to examine:
• Defect-detection capability.
• Functional testing procedures.
• Software validation.
• Service and maintenance records.
• Quality-system maturity.
• Equipment compatibility.
• Cybersecurity and software controls.
• Recall-response procedures.
• Availability of replacement components.
• Post-installation technical support.
The commercial implication is that equipment price alone may not provide a sufficient basis for supplier selection.

Recent Innovation: Software and AI as Commercial Upgrades
The medical imaging market is increasingly moving toward AI-enabled and cloud-connected workflows.
At ECR 2026, GE HealthCare highlighted innovations across CT, MRI, mammography, molecular imaging, SPECT/CT and image-guided therapy, including cloud- and AI-enabled technologies designed to address clinical and operational pressures.
This creates a commercial opportunity for suppliers that can connect imaging innovation with measurable operational outcomes.
Rather than selling AI as a standalone feature, suppliers can position software around:
• Faster workflow.
• Improved image reconstruction.
• Automated measurements.
• Clinical decision support.
• Workflow prioritization.
• Reduced manual processing.
• Better utilization of existing imaging infrastructure.
The FDA also issued final Clinical Decision Support Software guidance in January 2026, clarifying how certain software functions are treated under its medical-device framework.

Competitive Proof Points
The competitive landscape includes major imaging-equipment and healthcare-technology suppliers such as GE HealthCare, Siemens Healthineers, Philips, Canon Medical Systems, Fujifilm, Shimadzu and others.
GE HealthCare's 2026 ECR portfolio demonstrates the breadth of competition across CT, MRI, mammography, molecular imaging and image-guided therapy.
For buyers, the relevant comparison increasingly extends beyond equipment specifications to lifecycle support, software capabilities, service responsiveness, quality systems and upgrade pathways.

Get 20% complimentary customization within the report:
https://www.datamintelligence.com/customize/medical-imaging-market?mg

Regional Demand Lens

United States
The U.S. represents a highly regulated and technology-intensive medical imaging market. QMSR implementation, FDA software guidance and continuing recall activity increase the importance of quality systems, validation, supplier qualification and lifecycle management.

Europe
European demand is supported by hospital modernization, diagnostic capacity expansion and increasing interest in AI-assisted imaging. Suppliers must balance innovation with regulatory compliance and interoperability.

Asia-Pacific
Asia-Pacific remains an important growth region because of healthcare infrastructure expansion, increasing diagnostic demand and investments in advanced imaging systems. Japan, China and South Korea are significant technology and manufacturing markets.

Latin America
Growth opportunities are connected to healthcare infrastructure development, private diagnostic networks and modernization of imaging equipment. Service availability and total cost of ownership remain important purchasing considerations.

Middle East & Africa
Investment in hospitals, specialist medical centers and diagnostic infrastructure is creating demand for advanced imaging systems. Suppliers with strong service networks and local technical support can address equipment-availability requirements.

Key Players in the Medical Imaging Market

1. GE HealthCare
2. Siemens Healthineers
3. Koninklijke Philips N.V.
4. Canon Medical Systems Corporation
5. Fujifilm Holdings Corporation
6. Shimadzu Corporation
7. Hologic, Inc.
8. Carestream Health
9. Samsung Medison
10. Hitachi Healthcare

Commercial Opportunity: Improve Quality, Throughput and Manufacturing Readiness

The most immediate opportunity for U.S. medical imaging suppliers is not simply selling new equipment.
It is helping buyers solve measurable operational problems.
The strongest sales openings include:
• Software upgrades for installed imaging systems.
• Preventive and corrective service contracts.
• Automated quality-control systems.
• Specialized cardiology applications.
• AI-enabled image analysis.
• Workflow optimization.
• Equipment validation services.
• Cybersecurity and software assurance.
• Lifecycle-extension programs.
• Supplier qualification and compliance support.
For diagnostic centers, the commercial proposition can center on throughput and equipment availability. For cardiology departments, the focus can shift toward image quality, specialized applications and workflow integration. For manufacturers, quality-control automation and validation become central to production readiness.

Decision Takeaways

The 5.1% CAGR provides a steady market-growth signal, but the higher-intent opportunity in the United States is tied to quality, throughput and supplier qualification.
U.S. decision-makers should evaluate:
1. Recall and corrective-action exposure.
2. Quality-management system maturity.
3. Software validation and assurance.
4. Defect-detection and testing capabilities.
5. Equipment compatibility.
6. Service-contract economics.
7. Upgrade opportunities for installed systems.
8. Cardiology-specific applications.
9. Diagnostic-center throughput.
10. Long-term supplier support.

For vendors, the strongest commercial opening is to position medical imaging solutions around measurable improvements in quality, throughput and manufacturing readiness rather than relying solely on market-growth messaging.

For More Information:
https://www.datamintelligence.com/research-report/medical-imaging-market?mg

📌 Request for 2 Days FREE Dashboard Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us:
Sai Kiran
Business Development Manager
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, Lalitha Nagar, Habsiguda,
Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com

About Us
DataM Intelligence is a market research and consulting firm that delivers comprehensive end-to-end business solutions, covering everything from in-depth research to strategic consulting. The company leverages key industry trends, insights, and developments to provide fast, reliable, and actionable solutions tailored to diverse client requirements.
It offers both syndicated and customized research reports supported by a strong and robust methodology. With an extensive database comprising 9000+ reports across 40+ industry domains, DataM Intelligence serves over 200 companies in more than 50 countries, helping organizations access critical business intelligence that drives informed decision-making and sustainable growth.

This release was published on openPR.